Effects of Tirofiban and Statins on High-Sensitivity C-Reactive Protein, Interleukin-6, and Soluble CD40 Ligand Following Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease

This study assessed the effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand after percutaneous coronary intervention in patients who had stable coronary artery disease. Tirofiban insignificantly limited the increase of soluble CD40 ligand after revascularization, especially in patients who had high levels of this marker at baseline (p = 0.06), whereas statins significantly inhibited increases in interleukin-6 and, to a lesser extent, high-sensitivity C-reactive protein without affecting the soluble CD40 ligand.